전문분야

관상동맥질환 (협심증, 심근경색), 말초혈관질환, 심장판막질환, 심근질환, 심부전, 고혈압, 고지혈증, 동맥경화증, 심방세동

진료시간표

• 시간
• 월
• 화
• 수
• 목
• 금
• 토

• 오전
• O
• O
• O
• O
• 시술
• x

• 오후
• O
• O
• O
• O/시술
• 시술

약력

고려대학교 의과대학 의학박사 미국 Emory 대학 심장내과 임상교수 미국 Cornell 대학 심장내과 교환교수 고려대학교 구로병원 심혈관센터 소장 고려대학교 구로병원장 고려대학교 의료원 의무부총장 겸 의료원장 대한중재시술학회 회장 대한심장학회 이사장 미국 심장학회 정회원 대통령 자문 국가생명윤리심의의원 미국 심장학회 한국지부장 현) 1. 나은병원 심혈관센터 명예원장 2. 고려대학교 심혈관 연구소장 3. GS 남촌재단 이사

전문분야

관상동맥질환(협심증, 심근경색증), 고혈압, 판막질환, 심부전, 심혈관중재시술

진료시간표

• 시간
• 월
• 화
• 수
• 목
• 금
• 토

• 오전
• O
• O
• 시술
• O
• O
• 문의

• 오후
• O
• O
• 시술
• X
• 시술

약력

고려대학교 의과대학 의학박사 고려대학교 구로병원 내과 레지던트 고려대학교 혜화병원 심장내과 전임의 캐나다 몬트리올심장센타 연수 가천대학교 길병원 심장내과 교수 가천대학교 길병원 심장혈관센터장 고려대학교 안암병원 순환기내과 임상교수 중앙대학교 광명병원 순환기내과 임상진료교수 대한심혈관중재학회(KSIC) 이사장 대한심혈관합병증연구회(KCCC) 회장 대한심장학회(KSC) 재무이사 KVIS (혈관중재술연구회) 회장 대한심장학회(KSC) 회장 ENCORESEOUL 조직위원장 현) 나은병원 심장혈관센터 원장 논문- 1. Effect of denopamine on left ventricular function in patients with chronic heart failure 2. Experience in high-speed rotational coronary atherectomy (Rotablator). 3. Influence of stent expansion states on platelet deposition in an extracorporeal porcine arteriovenous shunt model using a multichannel perfusion channel 4. Successful management of a resistant, focal calcified lesion following direct coronary stenting with a cutting balloon. 5. Stents versus coronary-artery bypass grafting for left main coronary artery disease 6. Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization Investigators). 7. Real-Time 3-Dimensional Echocardiography of the Heart 13 Years After Partial Left Ventriculectomy. 8. Long-Term Safety and Efficacy of Stenting Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease 5-Year Results From the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) Registry. 9. Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial. 10. Comparison of zotarolimus-eluting stents versus sirolimus-eluting stents versus paclitaxel-eluting stents for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: results from the Korean Multicentre Endeavor (KOMER) acute myocardial infarction (AMI) trial. 11. Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) Randomized, Multicenter Study. 12. Repeated sudden cardiac death in coronary spasm: is IVUS helpful to decide treatment strategy 13. Outcomes after unrestricted use of everolimus-eluting and sirolimus-eluting stents in routine clinical practice: a multicenter, prospective cohort study 14. A comparison of two brands of clopidogrel in patients with drug-eluting stent implantation. 15. Predictors of recovery of left ventricular systolic dysfunction after acute myocardial infarction: from the Korean acute myocardial infarction registry and Korean myocardial infarction registry. 16. Everolimus-eluting Xience V/Promus versus Zotarolimus-eluting Resolute stent in patients with diabetes mellitus. 17. Trial of everolimus-eluting stents or bypass surgery for coronary disease. 18. Comparative effect on platelet function of a fixed-dose aspirin and clopidogrel combination versus separate formulations in patients with coronary artery disease: A phase IV, multicenter, prospective, 4-week non-inferiority trial. 19. Intravascular ultrasound-guided retrograde percutaneous coronary intervention of a chronic total occlusion. 20. Renal denervation for treatment of uncontrolled hypertension in an Asian population: results from the Global SYMPLICITY Registry in South Korea (GSR Korea). 21. Clinical Outcomes according to the Achievement of Target Low Density Lipoprotein-Cholesterol in Patients with Acute Myocardial Infarction 22. Predictors and Long-Term Clinical Outcome of Longitudinal Stent Deformation: Insights From Pooled Analysis of Korean Multicenter Drug-Eluting Stent Cohort. 23. Randomized Prospective Comparison of Everolimus-Eluting vs. Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention- 3-Year Clinical Outcomes of the EXCELLENT Randomized Trial 24. A multicenter, randomized, and double-blind phase IV clinical trial to compare the efficacy and safety of fixed-dose combinations of amlodipine orotate/valsartan 5/160 mg versus valsartan/hydrochlorothiazide 160/12.5 mg in patients with essential hypertension uncontrolled by valsartan 160 mg monotherapy 25. Ten-Year Outcomes of Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease. 26. The effects of DPP4 inhibitors on the levels of plasma catecholamines and their metabolites in patients with type 2 diabetes. 27. Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial. 28. Efficacy and Safety of Dual-Drug-Eluting Stents for de Novo Coronary Lesions in South Korea—The Effect Trial. 29. Impact of genetic variants on clinical outcome after percutaneous coronary intervention in elderly patients. 30. Successful Long-term Patency of a Complicated Coronary Aneurysm at a Prior Coronary Branch Stent Treated with a Stent Graft and Dedicated Bifurcation Stent. 31. Long-term outcomes after renal denervation in an Asian population: results from the Global SYMPLICITY Registry in South Korea (GSR Korea). 32. Transplantation of 3D bio-printed cardiac mesh improves cardiac function and vessel formation via ANGPT1/Tie2 pathway in rats with acute myocardial infarction. 33. LEFTY-PITX2 signaling pathway is critical for generation of mature and ventricular cardiac organoids in human pluripotent stem cell-derived cardiac mesoderm cells. 34. Clinical Outcomes in Patients with Delayed Hospitalization for Non-ST Elevation Myocardial Infarction. 35. A Comparative Analysis of Two Biolimus-Eluting Biodegradable Stents: Evaluation of the Equivalence of 6 Months Versus 12 Months of DAPT Following Biolimus-Eluting Stent Implantation in Acute Coronary Syndrome (EQUUS). 36. Target Low-Density Lipoprotein-Cholesterol and Secondary Prevention for Patients with Acute Myocardial Infarction: A Korean Nationwide Cohort Study. 37. Early Invasive Strategy Based on the Time of Symptom Onset of Non-ST-Segment Elevation Myocardial Infarction. 38. Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque: Rationale and Design of the Randomized, Controlled PREVENT Trial. 39. Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial. Lancet. 2024 May 4;403(10438):1753-1765 40. Association between body mass index and three-year outcome of acute myocardial infarction. Sci Rep. 2024 Mar 1;14(1):365 41. Association of Age- and Body Mass Index-Stratified High On-Treatment Platelet Reactivity With Coronary Intervention Outcomes in East Asian Patients. J Am Heart Assoc. 2024 May 7;13(9):e031819 42. Prediction of longitudinal clinical outcomes after acute myocardial infarction using a dynamic machine learning algorithm. Front Cardiovasc Med. 2024 Apr 5;11:1340022 43. Efficacy and Safety of Sirolimus-Eluting Stent with Biodegradable Polymer Ultimaster™ in Unselected Korean Population: A Multicenter, Prospective, Observational Study From Korean Multicenter Ultimaster Registry. Korean Circ J. 2024 Apr 22. 44. Prognostic Impact of CYP2C19 Genotypes on Long-Term Clinical Outcomes in Older Patients After Percutaneous Coronary Intervention. J Am Heart Assoc. 2024 May 21;13(10):e032248. 저서 1. 심혈관중재매뉴얼(2016), 발행인, 저자, 대한심혈관중재학회(ISBN: 978-89-965763-3-4 93510) 2. VIS Manual(2012), 대표저자, 군자출판사(ISBN 978-89-6278-565-4) 3. KVIS Manual (2016). 저자, 혈관중재시술연구회(ISBN 978-89-97156-20-7) 4. 관동맥완전폐색병변의 시술매뉴얼(2016), 저자, 군자출판사(ISBN 978-89-6278-494-7) 5. 심혈관합병증 매뉴얼(2017), 저자, 대한심혈관합병증연구회(ISBN 978-89-97156-29-3) 6. 심혈관중재매뉴얼 업데이트(2022), 저자, 대한심혈관중재학회(ISBN 978-89-965763-4-1 93510) 7. 심근경색증 개정판(2022), 저자, 도서출판대한의학(ISBN 979-11-559022-0-2)

전문분야

심혈관질환, 고혈압, 심부전, 판막질환, 고지혈증, 심혈관중재시술

진료시간표

• 시간
• 월
• 화
• 수
• 목
• 금
• 토

• 오전
• O
• O
• O
• 시술
• 시술
• 문의

• 오후
• O
• 시술
• X
• O
• O

약력

가톨릭대학교 의과대학 졸업 가톨릭대학교 의과대학원 의학박사 가톨릭대학교 성바오로병원 순환기내과 임상조교수 명지성모병원 심장내과 과장 가톨릭대학교 부천성모병원 순환기내과 임상조교수 서귀포 의료원 심장내과 과장 및 심뇌혈관센터장 청주 효성병원 심장내과 과장 평택성모병원 심장내과 과장 대한심혈관중재학회 중재시술 인증의 대한심장초음파학회 심초음파 인증의 대한고혈압학회 정회원 대한내과학회 정회원 대한심장학회 정회원 가톨릭대학교 의과대학 대학원 학술상 대한고혈압학회 제22회 춘계학술대회 최우수 젊은 연구자상 <해외 SCI(E)논문 10편 발표 (제1저자, 교신저자)> 현) 나은병원 심장내과 과장

전문분야

심장혈관중재시술/허혈성 심질환(협심증,심근경색)/말초혈관질환/고혈압, 고지혈증, 심부전/ 부정맥, 서맥

진료시간표

• 시간
• 월
• 화
• 수
• 목
• 금
• 토

• 오전
• O
• 시술
• O
• O
• O
• 문의

• 오후
• 시술
• X
• O
• 시술
• O

약력

전북대학교 의학전문대학원 의학과 졸업 고려대학교 구로병원 인턴 고려대학교 구로병원 내과 전공의 고려대학교 구로병원 순환기내과 임상강사 대한내과학회 정회원 대한심장학회 정회원 대한심혈관중재학회 정회원 대한심초음파학회 정회원 현) 나은병원 심장내과 과장